Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Caladrius Bio (NQ: CLBS )

1.530 USD -0.020 (-1.29%)
Official Closing Price Updated: 7:35 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Caladrius Bio

< Previous 1 2 3 4 5 6 7 8 Next >
Analysts Expect VXF Will Reach $132
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Caladrius Biosciences Reports 2019 First Quarter Financial Results and Provides Corporate Update
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company pioneering advancements of cell therapies in select... 
From GlobeNewswire News Releases
Caladrius Biosciences to Participate at the Upcoming May Conferences
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the development of innovative products that have... 
From GlobeNewswire News Releases
Caladrius Biosciences to Host 2019 First Quarter Financial Results Conference Call on Thursday, May 9, 2019 at 4:30 p.m. Eastern Time
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the development of innovative products that have... 
From GlobeNewswire News Releases
The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags OPNT SNY BTX
From Benzinga
New Research: Key Drivers of Growth for Sunworks, Murphy, WNS (Holdings), Caladrius Biosciences, Full House Resorts, and Kewaunee Scientific — Factors of Influence, Major Initiatives and Sustained Pro
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Sunworks, Inc.... 
From GlobeNewswire News Releases
The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags TEVA FDA RVNC
From Benzinga
Caladrius Biosciences to Participate in Upcoming Conferences
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the development of innovative products that have... 
From GlobeNewswire News Releases
Caladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial Results
From ACCESSWIRE
Caladrius Biosciences announces Purchase Agreement with Lincoln Park Capital for up to $26 million
From ACCESSWIRE
Caladrius Biosciences to Host 2018 Fourth Quarter and Year End Financial Results Conference Call on Thursday, March 14, 2019 at 4:30 p.m. Eastern Time
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the development of innovative products that have... 
From GlobeNewswire News Releases
Caladrius Biosciences to Present at the Alliance for Regenerative Medicine 7th Annual Cell & Gene Therapy Investor Day
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the development of innovative products that have... 
From GlobeNewswire News Releases
Analysts Expect IWC To Hit $120
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
LSI Builds on Business Momentum, Appoints New Chairman
LSI today announced the appointment of Steven Myers as chair of its board of directors, effective immediately. 
From Business Wire News Releases
71 Biggest Movers From Yesterday
Gainers Arcimoto, Inc. (NASDAQ: FUV) shares jumped 108.82 percent to close at $7.10 on Thursday. The stock may be moving in ... 
Tags CRY ALRN EEX
From Benzinga
52 Stocks Moving In Thursday's Mid-Day Session
Gainers Arcimoto, Inc. (NASDAQ: FUV) shares climbed 66.5 percent to $5.66. The stock may be moving in sympathy with ... 
Tags Intraday Update NSIT CYBR
From Benzinga
Mid-Day Market Update: Invacare Surges Following Strong Q4 Results; Motif Bio Shares Slide
Midway through trading Thursday, the Dow traded down 0.56 percent to 25,399.80 while the NASDAQ declined 0.15 percent to 7,409.20. The ... 
Tags News Mid/Day Market Update FUV
From Benzinga
Mid-Morning Market Update: Markets Open Lower; Cisco Earnings Top Estimates
Following the market opening Thursday, the Dow traded down 0.44 percent to 25,429.69 while the NASDAQ declined 0.05 percent to 7,416.78. ... 
Tags FUV News Benzinga
From Benzinga
The Daily Biotech Pulse: Vanda Q4 Results, Inovio Debt Offering, Caladrius Diabetes Drug Flunks Mid-Stage Trial
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags NVS Offerings IONS
From Benzinga
Caladrius Biosciences Reports Top-Line Data for the Phase 2a Sanford Project: T-Rex Trial of CLBS03 for Recent Onset Type 1 Diabetes
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company with multiple development programs targeting select... 
From GlobeNewswire News Releases
Caladrius Biosciences to Present at Upcoming February Conferences
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company with multiple technology platforms targeting select... 
From GlobeNewswire News Releases
Caladrius Biosciences to Participate in Upcoming January Conferences
Caladrius Biosciences to Participate in Upcoming January Conferences 
From GlobeNewswire News Releases
20 Stocks Moving In Monday's Pre-Market Session
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares rose 42.9 percent to $5.00 in pre-market trading after the company ... 
Tags FLNT PER Trading Ideas
From Benzinga
48 Biggest Movers From Yesterday
Gainers Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) climbed 100 percent to close at $2.80 on Thursday after the company reported ... 
Tags EXPR Movers From Yesterday CPRX
From Benzinga
Recent Analysis Shows Escalade, Caladrius Biosciences, LightInTheBox Holding Co., Vishay Intertechnology, Ceridian HCM Holding, and Avista Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Escalade, Incorporated... 
From GlobeNewswire News Releases
70 Biggest Movers From Yesterday
Gainers Apptio, Inc. (NASDAQ: APTI) shares jumped 51.51 percent to close at $37.65 on Monday after the company agreed to be ... 
Tags Movers MHLD ISCA
From Benzinga
54 Stocks Moving In Monday's Mid-Day Session
Gainers Reshape Lifesciences Inc (NASDAQ: RSLS) jumped 186 percent to $6.35 after the company earlier announced the completion of ... 
Tags STM NAT News
From Benzinga
Caladrius Biosciences to Participate in the Inv€$tival Showcase in Partnership with Jefferies and the Jefferies 2018 London Healthcare Conference
Caladrius Biosciences to Participate in the Inv€$tival Showcase in Partnership with Jefferies and the Jefferies 2018 London Healthcare Conference 
From GlobeNewswire News Releases
Caladrius Biosciences Reports 2018 Third Quarter Financial Results
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company with multiple technology platforms targeting select... 
From GlobeNewswire News Releases
Caladrius Biosciences Appoints Cynthia Schwalm to Board of Directors
Caladrius Biosciences Appoints Cynthia Schwalm to Board of Directors 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.